GGrantIndex
Sort

15,842 grants matching pancreatic cancer

A stress inducible Pdx1 transcriptional complex governing beta cell survival

$451,633
Doris A. Stoffers · University Of Pennsylvania · R01 · FY2022 · DK

(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)

$451,597
Jill C Fehrenbacher · Indiana University Indianapolis · R01 · FY2022 · CA

Physical Activity, Energy Balance, and Cancer

$451,525
Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Surgical Studies of GI Peptides - Mechanisms of Action

$451,448
University Of Texas Medical Br Galveston · R01 · FY2004 · DK

Glutamine synthetase in cancer cell metabolism and oncogenesis

$451,360
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA

Glutamine synthetase in cancer cell metabolism and oncogenesis

$451,360
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA

Defining pro-metastatic drivers in the pancreatic cancer tumor microenvironment

$451,313
Michael Paul Kim · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma

$450,924
Anthony G Christodoulou · University Of California Los Angeles · R01 · FY2024 · EB

Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer

$450,894
Or P. Gozani · Stanford University · R01 · FY2023 · CA

University of Minnesota Clinical Center for the Study of Pancreatic Disease

$450,856
Melena D. Bellin · University Of Minnesota · U01 · FY2023 · DK

Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer

$450,830
Andrea Viale · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer

$450,830
Andrea Viale · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Metaplastic Tuft Cells in Pancreatic Cancer

$450,764
Howard C Crawford · Henry Ford Health System · R01 · FY2024 · CA

An innovative integrated computational framework using gene signatures for patient stratification

$450,696
Chao Cheng · Baylor College Of Medicine · R01 · FY2025 · CA

The role of wild-type KRAS in the context of tumor profession and metastasis

$450,563
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2018 · CA

Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation

$450,373
Helen M Piwnica-Worms · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis

$450,103
Seema Khan · Northwestern University At Chicago · N01 · FY2017 · CA

Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer

$450,008
Michael Bouvet · University Of California, San Diego · R01 · FY2025 · CA

Chemical Applications of Floquet State Spectroscopy

$450,000
John C Wright · University Of Wisconsin-Madison · · FY2022 · MPS

Multiplexed Serum Biomarkers for Pancreatic Cancer

$450,000
University Of Pittsburgh At Pittsburgh · U01 · FY2005 · CA

Pancreatic Cancer Genetic Epidemiology Consortium

$450,000
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2007 · CA

Rational in situ programming of cancer vaccine-responding T-cell clones

$449,968
Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Novel Determinants and Measures of Smokeless Tobacco Use

$449,810
Dorothy K Hatsukami · University Of Minnesota · R01 · FY2013 · CA

Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniae

$449,794
Jason J. Gill · Texas A&M Agrilife Research · R33 · FY2019 · AI

Neurogenic Amplification of Pancreatitis Pain

$449,754
Karin N Westlund-High · University Of Kentucky · R01 · FY2012 · NS